INM
InMed Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$1.36
−2.16%Margins
Gross margin
14.9%
EBITDA margin
-0.5%
EBIT margin
-0.5%
Net margin
-0.6%
FCF margin
-0.5%
-1168.4%
Return on equity
-414.5%
Return on assets
-995.4%
Return on invested capital
338.72x
Asset turnover
-$10.1M
Cash from operations
$0.41
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026